Professional Documents
Culture Documents
Microbiology For Clinicians: Interpreting Culture Results
Microbiology For Clinicians: Interpreting Culture Results
Microbiology For Clinicians: Interpreting Culture Results
Course roadmap
Basic concepts
Common infections
1
“The future of antibiotics
World Antibiotic depends on all of us.”
Awareness Week
2019
2
Core Competencies
Core competencies for
antimicrobial prescribing
C1: Understands the patient and the patient’s clinical needs
C2: Understands treatment options and how they support the
patient’s clinical needs
C3: Works in partnership with the patient and other healthcare
professionals to develop and implement a treatment plan
C4: Communicates the treatment plan and its rationale clearly to
the patient and other health professionals
C5: Monitors and reviews the patient’s response to treatment
3
Objectives
• Recognize the importance of appropriate specimen
collection in the interpretation of microbiologic data
• Utilize clinical data to appropriately interpret
microbiologic data in order to distinguish colonization
or and contamination from infection
• Accurately interpret antimicrobial susceptibility data
4
5
Number of bacterial cells
in and on a human body is
equal to or exceeds the
number of human cells!
6
Does the microbiologic data make sense?
Review Evaluate
Check for
micro- Assess route &
adverse
biologic spectrum duration of
effects
data therapy
WHO/A. Kristensen
8
Inappropriate use of antimicrobials can
lead to considerable harm.
9
Culture results could represent….
Colonization
Contamination
Infection
10
Culture results could represent….
11
Culture results could represent….
Exogenous microorganisms
Contamination introduced into a specimen
12
Culture results could represent….
Infection Disease
13
Core Competencies 1, 2, 3, 4
Case 1
Diagnostic
work-up
Clinical
Clinical Therapeutic re-assessment Modify
assessment decisions antimicrobials
Data
Patient review
education
Initial evaluation Subsequent evaluation
14
65 year-old female patient who:
15
16
Diagnostic challenge
Contaminant Infection
17
Diagnostic challenge
Contaminant Infection
18
Diagnostic challenge
Contaminant Infection
19
Methodology is critical to the interpretation
of blood culture results
Technique
Methodology is critical to the interpretation
of blood culture results
Separate
Blood veni-
Technique Timing
volume puncture
sites
Chance of pathogen recovery in blood
culture
+30% +13% +7%
Blood
volume
10 mL 20 mL 30 mL 40 mL
Volume of blood
Cockerill et al, CID 2004
Methodology is critical to the interpretation
of blood culture results
Separate
Blood veni-
Technique Timing
volume puncture
sites
Methodology is critical to the interpretation
of blood culture results
Separate
Blood veni-
Technique Timing
volume puncture
sites
Interpreting blood culture results
25
Interpreting blood culture results
26
Interpreting blood culture results
27
Interpreting blood culture results
28
Core Competencies 1, 2, 4, 5
An informed re-evaluation
Review Evaluate
Check for
micro- Assess route &
adverse
biologic spectrum duration of
effects
data therapy
Optimal antibiotics
29
Does the microbiologic data make sense?
Review Evaluate
Check for
micro- Assess route &
adverse
biologic spectrum duration of
effects
data therapy
30
Does the microbiologic data make sense?
Review Evaluate
Most Check for
likely skin contamination ofroute &
micro- Assess
adverse
biologic spectrum blood culture duration of
effects
data therapy
31
Key points
• Obtain blood from culture from
separate venipuncture sites to
assist in distinguishing
contaminant from true infection.
32
Core Competencies 1, 2, 3, 4
Case 2
Diagnostic
work-up
Clinical
Clinical Therapeutic re-assessment Modify
assessment decisions antimicrobials
Data
Patient review
education
Initial evaluation Subsequent evaluation
33
62 year-old male patient with:
Diabetes mellitus
34
Microbiologic data
• Superficial foot swab
without debridement
• Culture grew:
• MSSA
• Anaerobes
• Pseudomonas
aeruginosa
WHO/A. Kristensen
35
36
Diagnostic challenge
Colonization Infection
37
Diagnostic challenge
38
Core Competencies 1, 2, 3, 4
Case 2
Diagnostic
work-up
Clinical
Clinical Therapeutic re-assessment Modify
assessment decisions antimicrobials
Data
Patient review
education
Initial evaluation Subsequent evaluation
39
Core Competencies 3
Case 2
• MRI: osteomyelitis
• Day 3: Diagnostic
tobramycin
work-up
discontinued due to Clinical
Clinical acute renal injury
Therapeutic re-assessment Modify
assessment decisions antimicrobials
• Underwent surgical Data
debridement
Patient review
education
Initial evaluation Subsequent evaluation
40
Does the microbiologic data make sense?
Review Evaluate
Check for
micro- Assess route &
adverse
biologic spectrum duration of
effects
data therapy
41
Verify the spectrum of therapy
Review Evaluate
Check for
micro- Assess route &
adverse
biologic spectrum duration of
effects
data therapy
42
Unintended consequences?
Review Evaluate
Check for
micro- Assess route &
adverse
biologic spectrum duration of
effects
data therapy
43
Key points
• Skin ulcers are colonized with
bacteria.
• If no clinical features of
infection, no antibiotic therapy
is necessary
• If osteomyelitis suspected,
pursue appropriate cultures
44
Minimum inhibitory concentration (MIC)
• Lowest concentration of an
antimicrobial that inhibits
visible growth in vitro
• Reference microbiology
organizations provide
interpretive guidelines
WHO/O. Karatuna
45
Core Competencies 3
Case 2
Diagnostic
work-up
Clinical
Clinical Therapeutic re-assessment Modify
assessment decisions antimicrobials
Data
Patient review
education
Initial evaluation Subsequent evaluation
46
MSSA
Measured EUCAST
zone interpretation
diameter
Cefoxitin (FOX30) 26 mm susceptible
Erythromycin (E15) 27 mm susceptible
Clindamycin (DA2) 27 mm susceptible
Fusidic acid (FD10) 31 mm susceptible
WHO/O. Karatuna
47
Review: Microbiology for Clinicians
Drug
prescription
Dose .............
.............
Route
.............
Duration
48
Quiz time!
Please click
“Next” to
proceed.